Rafael Holdings Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Rafael Holdings şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

-1.2%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-1.2%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Rafael stepping back from early-stage development in favor of acquisition, licensing

Nov 16

Is Rafael Holdings (NYSE:RFL) Using Debt In A Risky Way?

Jan 20

Rafael Holdings: A Coin Flip

Nov 18

Rafael Holdings announces merger with Rafael Pharmaceuticals

Jun 21

Rafael Holdings adds three new members to board

Jun 14

What You Need To Know About Rafael Holdings, Inc.'s (NYSE:RFL) Investor Composition

Jan 25

Rafael Holdings reports FQ1 results

Dec 15

The Rafael Holdings (NYSE:RFL) Share Price Has Gained 29% And Shareholders Are Hoping For More

Dec 01

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: RFL şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: RFL şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Rafael Holdings Piyasaya Karşı Temettü Getirisi

RFL temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (RFL)	n/a
Pazarın Alt %25'i (US)	1.3%
Pazarın En İyi %25'i (US)	4.2%
Sektör Ortalaması (Real Estate)	2.3%
Analist tahmini (RFL) (3 yıla kadar)	n/a

Önemli Temettü: RFL şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, RFL şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: RFL şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: RFL herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Rafael Holdings Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

Rafael Holdings, Inc. announced delayed annual 10-K filing

Rafael Holdings, Inc. announced delayed annual 10-K filing

Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet?

Rafael Holdings, Inc. (NYSE:RFL) entered into a definitive agreement to acquire unknown remaining stake of Cyclo Therapeutics, Inc. (NasdaqCM:CYTH).

New major risk - Financial position

Solid Earnings May Not Tell The Whole Story For Rafael Holdings (NYSE:RFL)

First half 2024 earnings released: EPS: US$0.10 (vs US$0.35 loss in 1H 2023)

Less than half of directors are independent

First quarter 2024 earnings released: US$0.15 loss per share (vs US$0.22 loss in 1Q 2023)

Rafael Holdings, Inc., Annual General Meeting, Jan 10, 2024

Full year 2023 earnings released: US$0.36 loss per share (vs US$6.21 loss in FY 2022)

Rafael Holdings, Inc. Announces Resignation of Rachel Jonas as Director

We Think Rafael Holdings (NYSE:RFL) Needs To Drive Business Growth Carefully

First half 2023 earnings released: US$0.35 loss per share (vs US$5.86 loss in 1H 2022)

Rafael Holdings, Inc. Announces Resignation of David Polinsky as Chief of Staff

First quarter 2023 earnings released: US$0.22 loss per share (vs US$5.88 loss in 1Q 2022)

Rafael Holdings GAAP EPS of -$0.22

Rafael Holdings, Inc., Annual General Meeting, Jan 23, 2023

Rafael stepping back from early-stage development in favor of acquisition, licensing

Founder & Chairman notifies of intention to sell stock

Rafael Holdings, Inc.(NYSE:RFL) dropped from Russell 2000 Dynamic Index

Third quarter 2022 earnings released: US$0.28 loss per share (vs US$0.15 loss in 3Q 2021)

Rafael Holdings, Inc. Announces Directorate Changes

Is Rafael Holdings (NYSE:RFL) Using Debt In A Risky Way?

Rafael Pharmaceuticals Announces Ongoing Successful Enrollment and Opening of Additional Sites for Phase 2 Clinical Trial of Cpi-613® (Devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer

First quarter 2022 earnings: Revenues in line with analyst expectations

Rafael Holdings: A Coin Flip

Full year 2021 earnings released: US$1.49 loss per share (vs US$0.66 loss in FY 2020)

Rafael Holdings, Inc. announced that it has received $104.169835 million in funding from a group of investors

Rafael Holdings, Inc. announced that it expects to receive $104.16987 million in funding

Rafael Holdings, Inc.(NYSE:RFL) dropped from Russell Microcap Value Index

Rafael Holdings announces merger with Rafael Pharmaceuticals

Third quarter 2021 earnings released: US$0.15 loss per share (vs US$0.14 loss in 3Q 2020)

Rafael Holdings adds three new members to board

Second quarter 2021 earnings released

Rafael Holdings, Inc. Appoints Ameet Mallik as Chief Executive Officer, Effective May 1, 2021

New 90-day high: US$45.51

Rafael Holdings Names William Conkling as Chief Commercial Officer, Effective March 15, 2021

New 90-day high: US$28.00

What You Need To Know About Rafael Holdings, Inc.'s (NYSE:RFL) Investor Composition

New 90-day high: US$24.60

First quarter 2021 earnings released: US$0.091 loss per share

Rafael Holdings reports FQ1 results

New 90-day high: US$22.33

Rafael Pharmaceuticals Partners with Sara’s Cure and SARC for the Launch of Phase 2 Clinical Trial for CPI-613® (devimistat) in Combination with Hydroxychloroquine for Patients with Clear Cell Sarcoma of Soft

The Rafael Holdings (NYSE:RFL) Share Price Has Gained 29% And Shareholders Are Hoping For More

Rafael Holdings, Inc., Annual General Meeting, Jan 13, 2021

New 90-day high: US$21.65

Full year earnings released - US$0.66 loss per share

Rafael Holdings, Inc. to Report Q4, 2020 Results on Oct 29, 2020

New 90-day high - US$18.88

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin